Tag: iWalk
10 Highlights of the Year 2011 for the Carcinoid and Neuroendocrine Tumor Community
December 15, 2011
As the Carcinoid Cancer Foundation looks back on the year 2011, there were many significant events and advances for the carcinoid and neuroendocrine tumor (NET) community. Here are 10 of the year’s important stories:
1) The FDA approved the first…
READ MORE
Up-to-the-Minute: News for the Carcinoid and Neuroendocrine Tumor Community
June 12, 2011
The first device that simultaneously performs PET and MRI scans, a new alpha-emitter-based therapy for NET cancer patients with progressive therapy-resistant tumors, the first–ever randomized virtual clinical trial, over 100 abstracts on carcinoid…
READ MORE
